APOLLO RESEARCH AND INNOVATIONS
logo-new
  • Home
  • About Us
    • About ARI
    • Chairman's Message
    • Leadership & Management
    • Our Presence
  • Work Scope
    • Clinical Research
    • Device and Technology Validation
    • Investigator Initiated Studies
    • Innovation Incubation & Acceleration
  • Ethics Committee
  • Grab your Grants
  • Clinical Research Courses
    • Blogs
  • Ongoing Covid Studies
  • Events
    • Webinars
    • Other Activities
  • Careers
  • Contact Us
ONGOING COVID STUDIES
  Home   |   Ongoing Covid Studies
S.No. Sponsor Drug Name Apollo Centres
1 Medanta Institute of Education & Research Tocilizumab (Roche) New Delhi, Hyderabad, Chennai
2 Serum Institute of India Recombinant BCG vaccine Chennai, New Delhi
3 Apollo Hospitals Convalescent Plasma New Delhi, Chennai, Hyderabad, Kolkata, Mumbai, Ahmedabad
4 NARI- ICMR WHO Solidarity Trial Chennai AMH, Chennai AVH
5 Cadila Sepsivac Chennai, Madurai, Ahmedabad, Hyderabad
6 Glenmark Favipiravir + Umifenovir versus Favipiravir New Delhi, Chennai
7 SunPharma Nafomosat, AQCH New Delhi - 2, Chennai – 1
8 DRL/DRDO 2 deoxy 2D glucose Chennai, New Delhi
To know more about the studies, kindly drop a mail at info@apolloari.com